S. Abdalla

发表

Improvements of symptoms of Alzheimer`s disease by inhibition of the angiotensin system.

U. Quitterer, S. Abdalla, 2020, Pharmacological research.

Inhibition of ACE Retards Tau Hyperphosphorylation and Signs of Neuronal Degeneration in Aged Rats Subjected to Chronic Mild Stress

U. Quitterer, S. Abdalla, Ahmed El Hakim, 2015, BioMed research international.

Beta-Arrestin1 Prevents Preeclampsia by Downregulation of Mechanosensitive AT1-B2 Receptor Heteromers

U. Quitterer, S. Abdalla, Xuebin Fu, 2019, Cell.

The Angiotensin II AT2 Receptor Is an AT1Receptor Antagonist*

H. Lother, U. Quitterer, S. Abdalla, 2001, The Journal of Biological Chemistry.

Up-Regulation of the Cardiac Lipid Metabolism at the Onset of Heart Failure

T. Streichert, U. Quitterer, S. Abdalla, 2011, Cardiovascular & hematological agents in medicinal chemistry.

Pathological AT1R-B2R Protein Aggregation and Preeclampsia

U. Quitterer, S. Abdalla, 2021, Cells.

Increased AT1 receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness

H. Lother, U. Quitterer, S. Abdalla, 2001, Nature Medicine.

Involvement of the Amino Terminus of the B2 Receptor in Agonist-induced Receptor Dimerization*

H. Lother, U. Quitterer, S. Abdalla, 1999, The Journal of Biological Chemistry.

A cleavable signal peptide enhances cell surface delivery and heterodimerization of Cerulean-tagged angiotensin II AT1 and bradykinin B2 receptor.

U. Quitterer, S. Abdalla, A. Pohl, 2011, Biochemical and biophysical research communications.

Vasopressor meets vasodepressor: The AT1-B2 receptor heterodimer.

U. Quitterer, S. Abdalla, 2014, Biochemical pharmacology.

Na+ ions binding to the bradykinin B2 receptor suppress agonist-independent receptor activation.

K. Jarnagin, W. Müller-Esterl, U. Quitterer, 1996, Biochemistry.

The N-terminal Amino Group of [Tyr8]Bradykinin Is Bound Adjacent to Analogous Amino Acids of the Human and Rat B2 Receptor*

K. Jarnagin, W. Müller-Esterl, U. Quitterer, 1996, The Journal of Biological Chemistry.

AT1 receptor heterodimers and angiotensin II responsiveness in preeclampsia.

H. Lother, U. Quitterer, S. Abdalla, 2004, Seminars in nephrology.

Factor XIIIA Transglutaminase Crosslinks AT1 Receptor Dimers of Monocytes at the Onset of Atherosclerosis

H. Lother, U. Quitterer, Said AbdAlla, 2004, Cell.

Mesangial AT1/B2 receptor heterodimers contribute to angiotensin II hyperresponsiveness in experimental hypertension

H. Lother, U. Quitterer, S. Abdalla, 2007, Journal of Molecular Neuroscience.

Structure of the bradykinin B2 receptors' amino terminus.

A. Braun, W. Müller-Esterl, A. Roscher, 1996, Biochemistry.

AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration

H. Lother, U. Quitterer, Said AbdAlla, 2000, Nature.

Angiotensin II AT2 Receptor Oligomers Mediate G-protein Dysfunction in an Animal Model of Alzheimer Disease*

H. Lother, U. Quitterer, S. Abdalla, 2009, Journal of Biological Chemistry.

ACE Inhibition with Captopril Retards the Development of Signs of Neurodegeneration in an Animal Model of Alzheimer’s Disease

U. Quitterer, S. Abdalla, Xuebin Fu, 2013, International journal of molecular sciences.

Dominant Negative AT2 Receptor Oligomers Induce G-protein Arrest and Symptoms of Neurodegeneration*

H. Lother, U. Quitterer, S. Abdalla, 2009, Journal of Biological Chemistry.

Two distinct Ca2+ influx pathways activated by the bradykinin B2 receptor.

W. Müller-Esterl, U. Quitterer, S. Abdalla, 1996, European journal of biochemistry.

Discovery of Pathologic GPCR Aggregation

U. Quitterer, S. Abdalla, 2019, Front. Med..

Investigation of the Extracellular Accessibility of the Connecting Loop between Membrane Domains I and II of the Bradykinin B2 Receptor*

E. Zaki, U. Quitterer, S. Abdalla, 1999, The Journal of Biological Chemistry.